Bibliometric Analysis
Integrating Ophthalmology, Endocrinology, and Digital Health: A Bibliometric Analysis of Telemedicine for Diabetic Retinopathy
This comprehensive analysis reveals the evolving landscape of telemedicine in diabetic retinopathy (DR), highlighting key trends, global collaborations, and the pivotal role of AI and digital health technologies in enhancing screening, diagnosis, and management.
Executive Impact Summary
The research on telemedicine for diabetic retinopathy is rapidly expanding, with significant growth driven by technological advancements and the urgent need for accessible healthcare solutions. Our analysis reveals key performance indicators and global contributions.
0
Total Articles Analyzed
0
Annual Growth Rate (1998-2025)
0
Countries Contributing
0
Highest Avg. Citations per Article (Singapore)
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Research Trends
Key Contributors
Methodological Focus
Research Trends in Telemedicine for DR
The field has seen a marked increase in publications, particularly after 2010, peaking in 2020-2021, influenced by the COVID-19 pandemic accelerating remote healthcare adoption. Predictive analysis suggests continued growth, with publications projected to exceed 1000 by 2030. Key themes include public health, telehealth service models, and artificial intelligence applications. There's a strong emphasis on imaging-oriented strategies, with emerging interest in smartphone-centered approaches.
Leading Countries, Journals, and Authors
The United States leads in publication output, followed by China, Australia, and Canada. Singapore boasts the highest average citations per article and international collaborations. Telemedicine and e-Health and Journal of Telemedicine and Telecare are the most productive journals, reflecting the multidisciplinary nature involving ophthalmology, endocrinology, and health informatics. Key authors like Cavallerano, Silva, and Aiello have significant contributions.
Methodological Focus and AI Integration
The analysis highlights a significant focus on artificial intelligence (AI), deep learning, and digital imaging for diagnostic and screening purposes. AI-driven image analysis is central to advancing teleophthalmology for retinal disorders. Cost-effectiveness and patient adherence to screening guidelines are also major areas of research, with telemedicine offering promising solutions to improve access and reduce costs.
Diabetic Retinopathy Telemedicine Workflow
Patient Screening (DM Diagnosis)
→
Fundus Image Capture (Remote/Mobile)
→
Image Transmission to Specialists
→
AI-Assisted Image Analysis & Interpretation
→
Diagnosis & Severity Assessment
→
Remote Consultation & Follow-up
→
Timely Intervention & Management
Annual Growth Rate in DR Telemedicine Research
13.14% Average Annual Growth Rate (1998-2025)| Feature | Traditional Screening | Telemedicine Screening |
|---|---|---|
| Accessibility |
|
|
| Cost-Effectiveness |
|
|
| Patient Adherence |
|
|
| Technology Reliance |
|
|
Case Study: National Telemedicine DR Screening Program in Singapore
Singapore's national telemedicine program for DR screening demonstrated significant cost-effectiveness and improved patient access. By integrating digital fundus photography and remote interpretation, the program successfully screened a large population, identifying DR earlier and facilitating timely interventions. This initiative showcases how a well-structured telemedicine model can lead to better public health outcomes and resource optimization for chronic conditions.
Calculate Your Enterprise AI ROI
Estimate the potential annual savings and reclaimed operational hours by integrating specialized AI solutions into your workflow.
Potential Annual Savings
$0
Operational Hours Reclaimed
0
Your AI Implementation Roadmap
A phased approach to integrate advanced AI solutions into your enterprise, ensuring seamless transition and maximum impact.
Phase 1: Needs Assessment & Pilot Program
Evaluate current DR screening gaps, define target population, select appropriate telemedicine technology (e.g., smartphone-based fundus cameras, AI platforms), and launch a small-scale pilot in a specific region or clinic to gather initial data and refine workflows.
Phase 2: Technology Integration & Staff Training
Integrate chosen AI and telemedicine platforms with existing healthcare IT systems. Conduct comprehensive training for ophthalmologists, endocrinologists, general practitioners, and support staff on operating equipment, image quality standards, and secure data handling.
Phase 3: Scaled Deployment & Monitoring
Expand the telemedicine program to broader geographical areas or additional clinics. Establish robust monitoring systems for screening adherence, diagnostic accuracy, referral patterns, and patient satisfaction. Continuously collect data for performance evaluation.
Phase 4: Advanced AI Integration & Outcome Analysis
Enhance AI models for predictive analytics, personalized risk assessment, and integration with electronic health records for seamless patient management. Conduct long-term studies to assess impact on vision preservation, healthcare costs, and overall patient quality of life.
Ready to Transform Your Operations?
Schedule a personalized strategy session with our AI experts to explore how these insights can be tailored to your enterprise needs.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat